Uncategorized - August 2, 2021
Swedish scientists have developed a method for discovery of antiviral drugs
Researchers at Uppsala University and Karolinska Institutet have presented a new screening approach that focuses on the identification of virus-specific morphological changes in virus-infected cells. The new method focuses on identifying the changes (morphological profiles) that the virus induces on the infected cells by using a modified version of the Cell Painting protocol, an established […]
Uncategorized - July 21, 2021
A new Swedish immunotherapeutic cancer vaccine delivery-platform
SciLifeLab Group leader, Sara Mangsbo, Uppsala University, and her immunotherapeutic cancer vaccine delivery-platform, is now ready to leave the SciLifeLab Drug Discovery and Development platform (DDD). The immunotherapeutic cancer vaccine delivery platform is based on a new technique, called Adaptable Drug Affinity Conjugate (ADAC), that can help the immune system to detect “invisible” tumors and […]
Uncategorized - June 22, 2021
New analysis: Life science across the Øresund
The analysis provides facts and figures about commuting, workforce, investments, businesses and research in Medicon Valley, and it also highlights a crucial discussion about the unexploited collaboration potential in the region. The analysis, prepared by Øresundsinstituttet as part of the Interregproject Greater Copenhagen Life Science Analysis Initiative, shows for example that there are more than […]
Uncategorized - June 21, 2021
Construction starts on Uppsala Business Park’s new Research Hub
The first stages of the construction of a new advanced laboratory building in Uppsala have began. Research Hub is a concept for laboratory facilities, designed by C.F. Møller, that addresses small and mid-sized research companies. The concept is flexible, both in terms of size and in function, and it can be quickly adapted to specific […]
Clinical Trials - June 11, 2021
First patient enrolled in Oasmia trial
Oasmia Pharmaceutical has announced that the first patient has been dosed in a Phase 1b clinical trial of its Docetaxel micellar in patients with advanced prostate cancer. The trial is being conducted by the Swiss Group for Clinical Cancer Research (SAKK). “We are pleased to be partnering with SAKK on this trial which we believe […]
Business article - June 9, 2021
Umeå’s life science industry is on the rise
Employment has risen by more than 17 per cent per year and life science companies have attracted SEK 230 million in equity investment over the past two and a half years. This is stated in a press release from Umeå Biotech Incubator. “Two years ago we set a goal that the life science industry in […]
